NEWS
Wed Jan 30, 2013 10:46 AM CST

(Dow Jones) -- Monsanto Co. has bought assets from a California-based company that uses microbes to improve crop production.

Monsanto also said that it made an equity investment in Synthetic Genomics Inc. and that the two companies reached a multiyear agricultural research agreement

The purchase of assets from Agradis, which Synthetic Genomics co-founded in 2011, includes the collection of microbes as well as the company's name. Terms of the deal weren't disclosed.

The assets build upon Monsanto's agricultural biological platform, called BioDirect, launched last year. Agricultural biologicals generally refer to seed or crop treatments derived from natural materials.

Agradis has ...

Quick View
  • Xtend Moves Forward USDA has issued its final environmental impact statement recommending full deregulation of Monsan...
  • Land Market What could the next year hold for land values?
  • No Agreement on Tax Extenders White House spokesman Josh Earnest on Monday said in his daily briefing that the White House woul...
  • Senior Partners - 4 At-your-service consultants help you walk through estate planning from start to finish.
  • Dow's Gutsy Decision Dow's decision to launch Enlist offers some hand-selected growers a chance to test drive new tech...
  • Congress Reaches Funding Deal The overall Agriculture Department and related agencies bill would cost $20.5 billion for fiscal ...
  • Need To Bee Accurate A news story had the wires buzzing Tuesday afternoon after a report that EPA was set to restrict ...
  • Kub's Den The Dakotas lost more than $130 million in grain revenue during the 2013-14 marketing year compar...
  • Ask the Vet What can I do to improve udder quality in my herd?
Related News Stories
Vilsack: China Approves MIR 162
Vilsack: China OKs Viptera
GE Seed Markets Uncertain
GE Seed Markets Uncertain
Xtend Moves Forward
Former GMO Critic's Change
A Disease State of Mind
Know Your Alphabet
Production Blog
Kub's Den